NBQX disodium (FG9202 disodium) is a highly selective, competitive AMPA receptor antagonist with neuroprotective and anticonvulsant activities; it reduces pentylenetetrazole (PTZ)-induced seizures in rats and demonstrates neuroprotection in a rat focal ischemia model when administered intravenously at the time of middle cerebral artery (MCA) occlusion and again 1 hour post-occlusion.